Pharmaceutical Control of the
Human Microbiome

Selectively Targeting Bacteria to Improve Human Health

The microbiome, the genetic material contained by our symbiotic bacteria, contains roughly 2 million genes, 100-fold more than our human genome.

Creating Value Based on a
New Therapeutic Paradigm

—First to safely target the vast collection of microbial
gene products essential for human health.

Core technology enables identification of
bacterial targets implicated in numerous diseases.

Collaborations led by an experienced team that generates new chemical entities, conducts development programs, and execute regulatory strategies.